ALEAF - Aleafia Health Inc
OTC Market: OTCQB | Related ticker symbols: TSX: ALEF
- - September 13, 2022: If you can identify the winners in their early stage, they you can be successful. However, that requires ignoring the hype and recognizing the swindlers, and sticking to the basics of investing like identifying companies with good leadership who have a record of success.
Aleafia Health Inc (OTC: ALEAF, TSX: AH), formerly known as Canabo Medical Inc, is a cannabis health and wellness service company headquartered in Concord, Ontario, Canada. Aleafia Health has an array of cannabis products in its portfolio, including cannabis oils, capsules, edibles, cannabis-infused strips, vape cartridges, and more. Aleafia Health operates globally and is well known for its hang-dried, hand-trimmed products. Aleafia Health also operates a virtual network of cannabis clinics that consists of a group of highly skilled physicians and nurse practitioners. It also offers its product under several brands: Divvy, Sunday Market, Noon & Night, Nith & Grand, Kin Slips, Emblem brands, and more.
The main aim of Aleafia Health is to create a cannabis production ecosystem that combines low-cost cultivation techniques of producing cannabis with high-margin production of different cannabis products. They also possess an industry-leading same-day delivery system from their distribution center based in Toronto to ensure everyone gets their product on time. But, what makes Aleafia Health truly unique is that it is a data-driven company and takes a scientific approach to making its business decisions. Aleafia Health currently possesses over 75,000 unique patients and is currently an exclusive member of Unifor, Canada's largest private-sector union.
Aleafia Health Inc is also blessed with a versatile leadership team with a wide range of expertise from different fields. The team is led by MARK J. SANDLER, who is the chairman of the board and has over 38 years of experience as a member of the Ontario bar. He is also a senior partner of Cooper, Sandler, Shime & Bergman LLP and practices trial law in criminal and regulatory matters. Another prominent director member is LU GALASSO, a professional chartered accountant who works with Zzen Group of Companies, a real estate and manufacturing company. Other directors in Aleafia Health Inc include CARLO SISTILLI, IAN TROOP, DAVID PASIEKA and JON PEREIRA. 
In the last five years, Aleafia Health has shown remarkable growth, increasing its revenue constantly during this time. Their net revenue increased from 3,865.7 Million in 2017 to 36,083.0 million in 2021, which is over 132.65% year-over-year growth. This figure is impressive as the company grew by over 172.41% during the pandemic. A similar trend is seen on cost of goods sold (COGS) as the figure increased from 4,347.5 units to 74,183.0 units over a span of 5 years. However, despite the remarkable growth, Aleafia Health did experience a loss of -58.97% of total assets, largely because of depreciation and a loss of inventory.
Aleafia Health went through several funding rounds and has raised over $92.6M. Their latest funding was raised on March 9, 2021, from a Post-IPO Equity round. In terms of investors, Aleafia Health has several big names, including Cantor Fitzgerald Canada Corporation and Echelon Wealth Partners. Aleafia Health also has several Acquisitions under its name, with Emblem and Canabo Medical being the leading ones.
Aleafia Health receives steep competition from several other companies including Meta Growth (META), InMed Pharmaceuticals (IN), Zomedica Pharmaceuticals Corp.
On December 21, 2021 the company announced that it had secured a credit facility of up to $19 million. In May 2022 Aleafia reached an agreement with Steering Committee to exchange the existing convertible debentures for new convertible debentures maturing in 2024, 2026, and 2028. The new debt carries and interest rate of 8.5%. In addition, they received equity financing of $5.6 million.
On January 4, 2022 the company announced that it would not be paying the 12/31/21 interest payment on its convertible debt, and have initiated negotiations with debt holders to restructure the debt.
- Yahoo Finance. ALEAF Stock Profile. Retrieved on 11/22/2022.
- Aleafia Health Inc website. Retrieved on 11/20/2022.
- Wall Street Journal. ALEAF Financials. Retrieved on 11/19/2022.
- Crunchbase. [financials|Aleafia Health]. Retrieved on 11/20/2022.
- Market Beat. Aleafia Health Competitors. Retrieved on 11/22/2022.
- Aleafia Health Announces Agreement to Amend Convertible Debentures and Equity Financing of $5.6 Million. May 12, 2022.
As of 10/31/2022 there were 403,062,709 shares of ALEAF stock outstanding.
As of 10/31/2022 short interest was 10,371 shares, which represents 1 day to cover.
Symbol change from CAMDF to ALEAF on 6/11/2018.
- - March 1, 2022:
- - March 1, 2022:
No opinions so far.